References
- Azoulay E, Roux A, Vincent F, et al. A multivariable prediction model for Pneumocystis jirovecii pneumonia in hematology patients with acute respiratory failure. Am J Respir Crit Care Med. 2018;198(12):1519–1526. doi:10.1164/rccm.201712-2452OC
- Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367–1376. doi:10.1093/cid/ciz1008
- Giacobbe DR, Dettori S, Di Pilato V, et al. Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG. Crit Care. 2023;27(1):323. doi:10.1186/s13054-023-04608-1
- Li N, Cai Q, Miao Q, et al. High-throughput metagenomics for identification of pathogens in the clinical settings. Small Methods. 2021;5(1):2000792. doi:10.1002/smtd.202000792
- Maschmeyer G, Helweg-Larsen J, Pagano L, et al. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. J Antimicrob Chemother. 2016;71(9):2405–2413. doi:10.1093/jac/dkw158
- Jiang J, Bai L, Yang W, et al. Metagenomic next-generation sequencing for the diagnosis of pneumocystis jirovecii pneumonia in non-HIV-infected patients: a retrospective study. Infect Dis Ther. 2021;10(3):1733–1745. doi:10.1007/s40121-021-00482-y
- Bassetti M, Azoulay E, Kullberg BJ, et al. EORTC/MSGERC definitions of invasive fungal diseases: summary of activities of the Intensive Care Unit working group. Clin Infect Dis. 2021;72(suppl 2):S121–S127. doi:10.1093/cid/ciaa1751
- Clinical microbiology group of Chinese society of laboratory medicine, clinical microbiology group of Chinese Society of Microbiology and Immunology, society of clinical microbiology and infection of China international exchange and promotion association for medical and healthcare. Chinese expert consensus on metagenomics next-generation sequencing application on pathogen detection of infectious diseases. Chin J Lab Med. 2021;44(2):107–120. doi:10.3760/cma.j.cn114452-20201026-00794
- Grose WE, Bodey GP, Loo TL. Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother. 1979;15(3):447–451. doi:10.1128/AAC.15.3.447
- Cushion MT, Linke MJ, Ashbaugh A, et al. Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection. PLoS One. 2010;5(1):e8524. doi:10.1371/journal.pone.0008524